IRIS
AUDRITO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.752
NA - Nord America 2.196
AS - Asia 1.975
SA - Sud America 229
Continente sconosciuto - Info sul continente non disponibili 113
AF - Africa 63
OC - Oceania 4
Totale 10.332
Salva come PNG Salva come JPEG
Nazione #
NL - Olanda 3.762
US - Stati Uniti d'America 2.080
RU - Federazione Russa 807
SG - Singapore 738
IT - Italia 489
CN - Cina 375
HK - Hong Kong 326
VN - Vietnam 214
BR - Brasile 176
DE - Germania 144
FR - Francia 111
IE - Irlanda 111
GB - Regno Unito 94
BD - Bangladesh 75
CA - Canada 62
ID - Indonesia 56
SE - Svezia 41
IN - India 36
ES - Italia 32
MX - Messico 31
UA - Ucraina 28
BJ - Benin 27
FI - Finlandia 27
KR - Corea 26
PL - Polonia 22
AR - Argentina 18
CZ - Repubblica Ceca 17
IQ - Iraq 17
AT - Austria 15
JP - Giappone 15
ZA - Sudafrica 15
TR - Turchia 14
CH - Svizzera 13
PK - Pakistan 12
JO - Giordania 11
JM - Giamaica 8
LT - Lituania 8
VE - Venezuela 8
BE - Belgio 7
EC - Ecuador 7
CO - Colombia 6
MD - Moldavia 6
PH - Filippine 6
CR - Costa Rica 5
DZ - Algeria 5
IL - Israele 5
MY - Malesia 5
RO - Romania 5
TH - Thailandia 5
TW - Taiwan 5
AU - Australia 4
AZ - Azerbaigian 4
CL - Cile 4
GR - Grecia 4
IR - Iran 4
MA - Marocco 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
BG - Bulgaria 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
UY - Uruguay 3
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
EG - Egitto 2
GT - Guatemala 2
HR - Croazia 2
KE - Kenya 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
MU - Mauritius 1
MZ - Mozambico 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
TG - Togo 1
TN - Tunisia 1
Totale 10.220
Salva come PNG Salva come JPEG
Città #
Amsterdam 3.745
Hong Kong 325
Singapore 304
Council Bluffs 292
San Jose 260
Ashburn 203
Beijing 123
Dublin 111
Columbus 92
St Louis 88
New York 85
Los Angeles 82
Lauterbourg 74
Turin 71
Moscow 68
Milan 64
Hanoi 57
Ho Chi Minh City 51
Jakarta 44
Munich 41
Santa Clara 40
Vercelli 34
Novara 33
Buffalo 31
Jacksonville 30
Orem 30
Chicago 29
São Paulo 28
Cotonou 27
Frankfurt am Main 27
Boardman 26
Dallas 24
London 21
Warsaw 21
Manchester 20
Brooklyn 19
Atlanta 18
Seoul 18
Chennai 17
Denver 17
Falkenstein 17
Genoa 17
Mexico City 17
Brno 16
Chandler 16
Nuremberg 16
Rome 15
Toronto 15
Houston 14
Montreal 14
San Francisco 14
Tokyo 14
Dearborn 13
Stockholm 13
Helsinki 12
Phoenix 12
Poplar 12
Amman 11
Ankara 9
Omaha 9
Boston 8
Da Nang 8
Las Vegas 8
Rio de Janeiro 8
Shanghai 8
Vienna 8
Baghdad 7
Biên Hòa 7
Haiphong 7
Johannesburg 7
Philadelphia 7
Princeton 7
Bologna 6
Borgomanero 6
Brasília 6
Guangzhou 6
Hillsboro 6
Kingston 6
Lawrence 6
Naples 6
Tianjin 6
Tornaco 6
Wilmington 6
Alessandria 5
Belo Horizonte 5
Bexley 5
Guarulhos 5
Mumbai 5
Petaling Jaya 5
Querétaro 5
San Mateo 5
Sylmar 5
Valencia 5
Zurich 5
Brandon 4
Can Tho 4
Charlotte 4
City of London 4
Como 4
Dhaka 4
Totale 7.201
Salva come PNG Salva come JPEG
Nome #
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.981
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.978
Bi-directional crosstalk between NAD/NAMPT and IFN-γ/PD-L1axes in melanoma 185
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed and abundantly released from malignant pleural mesothelioma cells becoming a potential biomarker. 171
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets 145
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment 138
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 135
NAMPT in drug-resistant melanoma: linking NAMPT-dependent metabolic reprogramming and immune regulation 134
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 126
NAMPT and NNMT released via extracellular vesicles and as soluble mediators are distinguished traits of BRAF inhibitor resistance of melanoma cells impacting on the tumor microenvironment 124
NAMPT inhibition impairs mTOR-dependent regulation of translation in melanomaNAMPT inhibition impairs mTOR-dependent regulation of translation in melanoma. 121
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes? 121
Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma 117
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 109
P13-17: Effect of Ether Perfluoro Carboxyl Acid (PFAS) on Innate Immunity in Earthworms 106
The Extracellular NADome Modulates Immune Responses 106
Investigating the presence of eNAMPT/visfatin in human skimmed milk and milk fat globule membrane before and after Holder pasteurization. 102
HLA-G IS A COMPONENT OF THE CLL ESCAPE REPERTOIRE TO GENERATE IMMUNE SUPPRESSION: IMPACT OF HLA-G 14 BP (RS66554220) POLYMORPHISM 99
The hidden life of NAD+-consuming ectoenzymes in the endocrine system 98
Immunological method and kit for in vitro diagnosis of tumor and/or inflammatory diseases 94
Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes 94
Procedimento immunologico e kit per la diagnosi in vitro di patologie tumorali e/o infiammatorie 90
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors 88
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 88
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment 87
Extracellular nicotinate phosphoribosyltransferasebinds Toll like receptor 4 and mediatesinflammation 84
Abstract 2630: Nicotinamide activates the p53/miR-34a/SIRT1 tumor suppressor network leading to apoptosis of chronic lymphocytic leukemia cells 82
Targeting mitochondria by ss-31 ameliorates the whole body energy status in cancer-and chemotherapy-induced cachexia 82
NAMPT AND AUTOANTIBODIES: A POSSIBLE ASSOCIATION FOR AUTOIMMUNE DIAGNOSTICS? 81
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis 81
Impact of Holder pasteurization on protein and eNAMPT/Visfatin content in human breast milk 81
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 78
The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation 78
TBC1 domain-containing proteins are frequently involved in triple-negative breast cancers in connection with the induction of a glycolytic phenotype 77
Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties 77
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed and abundantly released from malignant pleural mesothelioma cells becoming a potential biomarker. 76
NAMPT: A critical driver and therapeutic target for cancer 76
Abstract 2302: The extracellular form of NAMPT contributes to creating a proinflammatory environment in chronic lymphocytic leukemia 74
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 73
Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network 71
Abstract 5170: Metabolism and cancer: The CD38-NAMPT connection in chronic lymphocytic leukemia 71
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 71
Effects of Ether Perfluoro Carboxyl Acids (PFECAs) on Innate Immunity in Earthworms (Eisenia fetida) 70
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 69
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 69
Editorial: Metabolic reprogramming in cancer 66
BI-DIRECTIONAL CROSSTALK BETWEEN NAD/NAMPT AND IFN-Γ/PD-L1 AXES IN MELANOMA 66
DIFFERENT AQUAPORIN-4 EXPRESSION IN GLIOBLASTOMA MULTIFORME PATIENTS WITH AND WITHOUT SEIZURES 66
Translational reprogramming in BRAF inhibitors resistant melanoma: the impact of NAMPT/NAD metabolism in mTOR-dependent regulation of protein synthesis. 65
The heme biosynthesis-heme export axis is required for the modulation of the tricarboxylic acid cycle 65
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma 65
BI-DIRECTIONAL CROSSTALK BETWEEN NAD/NAMPT AND IFN-Γ/PD-L1 AXES IN MELANOMA 63
Metabolic adaptation in colorectal cancer: heme export is required for the modulation of the tricarboxylic acid cycle 63
Special Issue: "Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets" 62
Loss of the heme exporter FLVCR1a impairs mitochondrial functionality: a new approach against colorectal cancer 60
CD38 in chronic lymphocytic leukemia: from bench to bedside? 59
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 59
Molecular insights into the interaction between human nicotinamide phosphoribosyltransferase and Toll-like receptor 4 59
The heme exporter FLVCR1a modulates the tricarboxylic acid cycle: a new target in colorectal cancer 58
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 57
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 56
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression 51
Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities 51
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation 50
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer 49
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 49
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 48
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS 47
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 47
Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT) 46
PRO-INFLAMMATORY ROLE OF EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE IN CYSTIC FIBROSIS 44
The dual face of NAMPT: Intracellular/extracellular protein and diagnostic/therapeutic target in cancer 44
Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications 44
SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy 43
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia 43
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics 43
Subcellular characterization of NAD+ biosynthesis in metastatic melanoma by using organelle-specific biosensors 42
Editorial: Tumor-host interactions: metabolic and signaling pathways altered in cancer, immune and stromal cells 41
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 41
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma 40
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options 40
Pancreatic cancer immune evasion mechanisms: the immunosuppressive role of P2RX1-negative neutrophils 37
Bi-directional regulation between NAD/NAMPT and IFN-γ/PD-L1 axes via BRD4/IRF1 and mitochondrial respiration in metastatic cutaneous melanoma 36
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model 36
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting 35
Regulation Of CLL Growth and Trafficking By The Enzymatic Functions Of CD38: Implications For Therapeutic Targeting 33
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer 31
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 31
null 23
Secondary amide derivatives of Fe(III)-CDTA: Impact of ligand substitution on relaxivity, stability, and kinetic inertness 20
Totale 10.332
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.275
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 4 1 1 0 2 2 1 5 4 8
2022/2023197 6 5 7 2 3 17 3 12 119 6 9 8
2023/2024389 13 26 32 18 62 4 86 33 6 5 22 82
2024/20251.346 46 5 119 34 92 54 177 91 456 53 56 163
2025/20267.742 167 153 171 403 416 340 508 597 4.035 418 280 254
2026/2027516 215 301 0 0 0 0 0 0 0 0 0 0
Totale 10.332